Partnership Will Focus on Developing a Continuous Glucose Monitoring System
to Work with Animas(R) Insulin Pumps
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM - News), a leading provider of
continuous glucose monitoring systems for people with diabetes, today announced
that it has entered into a joint development agreement with Animas Corporation
to integrate DexCom’s continuous glucose monitoring (CGM) technology into
Animas® insulin pumps.
No comments:
Post a Comment